HomeInsightsShare Holding

Gland Pharma Ltd Share Holding Pattern

Gland Pharma Ltd Share Holding Pattern

stocks purchased

₹ 2.2 Cr

Volume transacted

stocks purchased

12.4 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Promoters Holdings Over Time

Key Highlights

  • FIIs/FPIs increased their stake in the company by 3.29% from March 2024 to June 2024. Mutual funds increased their stake in the company by 7.52% from March 2024 to June 2024.
  • Promoters decreased their stake in the company by 6.02% from March 2024 to June 2024.

Latest Shareholding

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20241810.45
18 Sep 20241842.35
17 Sep 20241847.05
16 Sep 20241865.5
13 Sep 20241877.6
12 Sep 20241889.35
11 Sep 20241889.75
10 Sep 20241927.1
09 Sep 20241902.6
06 Sep 20241904.85

Gland Pharma Ltd News Hub

News

Gland Pharma Ltd slips for fifth straight session

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 18...

Read more

19 Sep 202413:35

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

07 Aug 202411:27

News

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspec...

Read more

05 Aug 202412:19

News

USFDA conducts surprise inspection of Gland Pharma's Dundigal facility

Gland Pharma announced that the United States Food and Drug Administration (US FDA) has co...

Read more

25 Jul 202413:49

News

Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received tentative approval from the United States Food and Drug Administ...

Read more

24 Jul 202410:09

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

Sep 2021

PPT

July 2021

TranscriptPPT

Feb 2021

Transcript

FAQs for EPS of Gland Pharma Ltd

On what factors does the shareholding pattern of Gland Pharma Ltd change frequently?

The shareholding pattern of Gland Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Gland Pharma Ltd's shareholding pattern updated?

The Gland Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Gland Pharma Ltd?

Categories included in the shareholding pattern of Gland Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Gland Pharma Ltd important for investors?

The shareholding pattern of Gland Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Gland Pharma Ltd?

The latest shareholding pattern of Gland Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*